8-K Filing

Company

Kairos Pharma, LTD.

Filed

October 4, 2024

Period of Report

October 1, 2024

Accession Number

0001493152-24-039586

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →